Truist analyst Youssef Squali raised the firm’s price target on Cimpress (CMPR) to $100 from $90 and keeps a Buy rating on the shares. The company’s Q2 results exceeded expectations, reflecting sustained demand for elevated, higher-value offerings with stabilization in the Y/Y decline in legacy products, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CMPR: